Disc Medicine, Inc.
IRON
$38.73
$3.509.94%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 19.36% | 10.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.16% | 6.50% | |||
| Operating Income | -5.16% | -6.50% | |||
| Income Before Tax | -10.56% | -0.73% | |||
| Income Tax Expenses | 54.39% | 90.00% | |||
| Earnings from Continuing Operations | -10.74% | -0.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.74% | -0.94% | |||
| EBIT | -5.16% | -6.50% | |||
| EBITDA | -5.16% | -6.84% | |||
| EPS Basic | -10.53% | 13.52% | |||
| Normalized Basic EPS | -10.33% | 13.69% | |||
| EPS Diluted | -10.53% | 13.52% | |||
| Normalized Diluted EPS | -10.33% | 13.69% | |||
| Average Basic Shares Outstanding | 0.20% | 16.71% | |||
| Average Diluted Shares Outstanding | 0.20% | 16.71% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
